TimesSquare Capital U.S. Mid Cap Growth Strategy highlighted stocks like Cencora, Inc. (NYSE:COR), in the third quarter 2024 investor letter. Cencora, Inc. (NYSE:COR) sources and distributes ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S ... This acquisition complements COR’s pharmaceutical-centric strategy, strengthens its Management Services Organization ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions ... This acquisition complements COR’s pharmaceutical-centric strategy, strengthens its Management Services ...

Knipper Health, a leading healthcare solutions organization serving the pharmaceutical, biotechnology, and medical device ...

We benefited from Cencora, Inc. (COR), which distributes ... exceeded expectations with steady organic growth. Management was upbeat regarding strategic initiatives that should improve sales ...

Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE ... nor predictions of a major slowdown could explain the growth seen in sectors beyond tech and communication services.

The Invesco S&P 500 Revenue ETF uses a revenue-weighted strategy ... with negative earnings growth over the past three years seen in names like Cencora and Cigna, but forward earnings growth ...

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...